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Development of an Ex Vivo Porcine Lung Model for Studying Growth,
Virulence, and Signaling of Pseudomonas aeruginosa
Freya Harrison, Aneesha Muruli, Steven Higgins, Stephen P. Diggle
School of Life Sciences, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom
Research into chronic infection by bacterial pathogens, such as Pseudomonas aeruginosa, uses various in vitro and live host
models. While these have increased our understanding of pathogen growth, virulence, and evolution, each model has certain
limitations. In vitromodels cannot recapitulate the complex spatial structure of host organs, while experiments on live hosts are
limited in terms of sample size and infection duration for ethical reasons; live mammal models also require specialized facilities
which are costly to run. To address this, we have developed an ex vivo pig lung (EVPL) model for quantifying Pseudomonas
aeruginosa growth, quorum sensing (QS), virulence factor production, and tissue damage in an environment that mimics a
chronically infected cystic fibrosis (CF) lung. In a first test of our model, we show that lasRmutants, which do not respond to
3-oxo-C12-homoserine lactone (HSL)-mediated QS, exhibit reduced virulence factor production in EVPL.We also show that lasR
mutants grow as well as or better than a corresponding wild-type strain in EVPL. lasRmutants frequently and repeatedly arise
during chronic CF lung infection, but the evolutionary forces governing their appearance and spread are not clear. Our data are
not consistent with the hypothesis that lasRmutants act as social “cheats” in the lung; rather, our results support the hypothesis
that lasRmutants are more adapted to the lung environment. More generally, this model will facilitate improved studies of mi-
crobial disease, especially studies of how cells of the same and different species interact in polymicrobial infections in a spatially
structured environment.
Pseudomonas aeruginosa commonly causes nosocomial infec-tions and is a particular danger for people with cystic fibrosis
(CF), in whom it establishes chronic lung infections (1). These are
virtually impossible to clear with current therapeutic regimes, due
to ciliary malfunction, the build-up of adhesive mucus in the CF
airways (2), antibiotic resistance, and P. aeruginosa’s ability to
produce protective polysaccharide capsules (3). People with CF
experience decades of chronic infection with repeated episodes of
acute pulmonary exacerbation (1). During this time, P. aeruginosa
evolves and diversifies; mutants with altered production of viru-
lence factors are commonly isolated from patients (4–11), as are
mutants that are impaired in quorum sensing (QS) (9, 10, 12).
Our understanding of the evolutionary pressures on P. aerugi-
nosa during chronic lung infection and how these may be medi-
ated by population or wider microbial community structure in
these spatially structured organs is currently limited (13–15). Yet
the evolutionary ecology of lung infections is likely a key factor in
morbidity and response to clinical interventions (13, 16).
To clarify the role played by different P. aeruginosa virulence
factors and by intermicrobial interactions in chronic infection, we
need model systems that closely mimic a lung environment but
are tractable in the lab and amenable to high-throughput experi-
ments. A variety of in vitro growth conditions and insect or rodent
hosts have been used to study P. aeruginosa populations. The pros
and cons of these systems are outlined in Table 1, along with those
of an underusedmodel host: ex vivo sections of porcine lung. This
model is useful for several reasons. First, pigs are arguably better
models for studying human disease than are rodents or inverte-
brates (17–19). Second, lungs can be obtained from butchers:
since little or no lung tissue is used in food production, lungs are
(i) cheap and (ii) a waste product whose use does not raise ethical
questions about the slaughter of animals for research. Third,many
small sections of tissue can be kept in culture for several weeks (20,
21). Finally, and crucially, the spatial structure of the tissue is
retained, and microbes can be visualized within the tissue by con-
ventional or confocal microscopy. Histopathological changes can
also be examined.
We developed this model for quantitative studies of P. aerugi-
nosa growth and exoproduct production.We focused on the well-
characterized PAO1 wild-type (WT) strain and two lasR mutant
strains which do not respond to the QS signal N-(3-oxodode-
canoyl)-L-homoserine lactone (3-oxo-C12-HSL) (49). QS con-
trols the expression of various exoproducts (49) and facilitates the
establishment of acute infection (31–36). However, mutants that
have lost LasR function and so do not respond to 3-oxo-C12-HSL
commonly arise in chronic CF infections (9, 10, 12) and ventila-
tor-associated pneumonia (50). There is debate over whether lasR
mutants are social “cheats” that benefit from the presence of WT
cells (51, 52) or whether they are adapted to the chronic lung
environment. Resolving this question is important because it will
affect the likely clinical success of QS inhibitors, which have been
suggested as novel antivirulence agents and antibiotic adjuvants
(53, 54). We therefore compared the growth of lasRmutants with
that of the WT in single-genotype and mixed infections in ex vivo
pig lungs (EVPL). We also measured the production of 3-oxo-
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C12-HSL and of two groups of virulence factors whose expression
is regulated by QS and that are linked with virulence in acute
infection or with acute exacerbation and declining lung function
in people with CF: tissue-degrading proteases (55) and redox-
active phenazines (55–57). We also assayed for the siderophores
pyoverdine and pyochelin, since these have been shown to be nec-
essary for acute infection (27, 58) and their role in chronic infec-
tion has been much discussed (59–62).
We report three key results: (i) we can detect differential pro-
duction of 3-oxo-C12-HSL, protease, and phenazine compounds
byWT andQSmutant P. aeruginosa colonizing EVPL; (ii) consis-
tent with this, lasR mutants cause less pathological change to the
host tissue; and (iii) lasRmutants grow as well as or better than the
WT in EVPL in single infections, and a marked lasR mutant had
fitness equal to that of the WT in a mixed infection. Therefore, in
this context, lasR mutants do not behave as social cheats: rather,
they grow well in this chronic infection model.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The Nottingham PAO1 strain
of P. aeruginosawas used as the wild type (WT). A PAO1mutant, carrying
a gentamicin resistance cassette inserted into the lasR gene, was used as a
marked lasR-null mutant (lasR::Gm) (26). For comparison, an unmarked
PAO1 clone with a clean deletion of lasR (lasR) was also used. Prelimi-
nary work suggested that levels of phenazines produced in our infection
model were too low to be assayed via spectrophotometry, so we used
PAO1WTandPAO1lasR strains carrying a reporter construct for one of
the main phenazine biosynthetic operons (phzA1-luxCDABE fusion; S.
Higgins, S. Heeb, G. Rampioni, P. Williams, N. Krasnogor, and M. Cá-
mara, unpublished data). Infected cubes of lung tissue were cultured in
artificial sputum medium (ASM) (24) for 24 h at 37°C on an orbital
shaker. ASM mimics the chemical composition of CF sputum but is not
viscous. All media used were supplemented with 50 g/ml ampicillin to
minimize the growth of any resident bacteria present in the lung cubes.
Preliminary work and observations. Lungs were purchased from a
butcher (A Holmes and Son, Coalville, Leicestershire, United Kingdom).
We conducted preliminary work on five lungs and determined that the
tissue was healthy and not damaged by the process of dissecting and pre-
paring tissue (see Fig. S1 in the supplemental material).We used the work
of Nunes et al. (42) as a starting point to develop a protocol for dissecting
out relatively regular cubes of alveolar tissue of approximately 5mm3 (125
l), inoculating with ca. 104 to 105 P. aeruginosa cells, and culturing the
infected cubes in ASM for up to 7 days. Finally, we determined that we
could visualize luminescent reporter bacteria in the cubes, homogenize
infected tissue to recover live bacteria, and conduct quantitative assays
with lung homogenate for the presence of 3-oxo-C12 HSL, total protease,
pyocyanin, and light production by luminescent (lux) reporters. We also
verified that resident lung bacteria were present at very low levels, being
almost entirely outcompeted by P. aeruginosa in infected tissue.
Ethics statement. All lung material was purchased from a retail
butcher and was sourced from animals already slaughtered for meat; eth-
ical approval was therefore not required for this study.
Preparation of lung material. The final protocol for the preparation,
inoculation, and culture of EVPL is shown in Fig. 1. Cubes of approxi-
mately 5 mm3 were dissected from the ventral surface of the left caudal
lobe of three sets of lungs using a sterile mounted razor blade. Large
bronchioles and veins were avoided in order to keep the cubes as compa-
rable as possible. Prior to dissection, the ventral surface of the pleura was
briefly (1 s) seared with a hot pallet knife to kill surface contaminants
from the abbatoir or butcher’s shop. This also rendered the pleura easier
to cut. During dissection, the tissue to be used was washed three times
with cell culturemedium (1:1mix of RPMI 1640 andDulbecco’smodified
Eagle medium [DMEM]; Sigma-Aldrich). The cubes were then washed
for a fourth time in ASM. Preliminary work confirmed that searing and
washing did not cause any visible damage to the pleura (light microscopy
of formalin-fixed tissue) and that these processes reduced the numbers of
contaminating and/or resident bacterial cells present in the cubes. We
aliquoted 400 l ASM supplemented with 0.8% agarose to individual
wells of a sterile 24-well plate (to provide a soft surface for the tissue to sit
on) and placed cubes singly in wells on this surface. Cubes were covered
with 500l liquid ASM. As a control experiment to explore the growth of
the bacterial strains in the absence of lung tissue, cultures were set up
exactly as described above, but in place of the lung cube, an extra 125 l
liquid ASM was added. Three experimental replicates of this experiment
were performed; in each case, five populations each of WT, lasR::Gm,
lasR, and WT plus lasR::Gm bacteria in a 1:1 mix were inoculated.
Inoculation of lung tissue. Bacterial strains were grown overnight in
lysogeny broth (LB), washed twice in phosphate-buffered saline (PBS),
and resuspended in ASM. Cubes were inoculated with ca. 104 washed
overnight-culture cells in 50 l ASM—or as a mock-infection control,
with 50l sterile ASM—using a 30-gauge needle attached to a disposable
1-ml syringe. Cubes were then incubated for 24 h at 37°C on an orbital
shaker. Figure S2 in the supplemental material shows a schematic of the
experiment.
Assays. After incubation, cubes were rinsed in 1 ml PBS to remove
loosely adhering cells. Growth of bacteria was assayed by homogenizing
cubes individually in 500 l phosphate-buffered saline with metal bead
tubes (Cambio) using a Precellys24 homogenizer, serially diluting the
homogenate and plating aliquots on LB plates to obtain single colonies.
To score the relative frequencies of WT and lasR mutant cells in mixed
infections, aliquots were replica plated onto LB plus 20g/ml gentamicin.
In mixed infections, the relative fitness of the mutant was calculated as
follows: v [x2(1 x1)]/[x1(1 x2)], where x1 and x2 are the initial and
final frequencies of the mutant in the population, respectively. When the
two genotypes have equal fitness, x1 x2 and v 1. v values of1 reflect
the mutant being outcompeted by theWT, and values of1 indicate that
the mutant outcompetes the WT. To quantify QS signals, total protease,
pyocyanin, and the siderophores pyoverdin and pyochelin, an aliquot of
the homogenate was diluted 10-fold in PBS and filtered using a 0.2-m
syringe-driven filter unit to remove cells. This was stored at20°C. The
FIG 1 Schematic of the final protocol for preparation, infection, and culture of EVPL.
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amount of the QS signal 3-oxo-C12-HSL in the diluted homogenates was
quantified using the pSB1075 Escherichia coli biosensor (63); briefly, 100
l of each homogenate was mixed with 100 l of an overnight biosensor
culture diluted to an optical density at 600 nm (OD600) of0.1, and the
luminescence/OD600 for each culture measured after 30 min of incuba-
tion at 37°C in a 96-well plate. The assay was calibrated using purified
3-oxo-C12-HSL. To measure total protease, 100 l homogenate was
mixed with 5 mg azocasein dissolved in 900 l 100 mM Tris-HCl plus 1
mM CaCl2, and the mixture was incubated with shaking for 15 min at
37°C; the reaction was then stopped by adding 500l 10% trichloroacetic
acid, and the absorbance of the supernatant was read at 400 nm. This assay
was calibrated using known concentrations of purified proteinase K. Pyo-
cyanin was quantified by measuring absorbance of homogenates at 695
nm, pyoverdine by exciting with light at 400 nm and measuring fluores-
cence at 460 nm (64) and pyochelin by exciting at 350 nm andmeasuring
fluorescence at 430 nm (65). To assay activity of the phzA1 phenazine
FIG 2 Micrographs of tissue after 24 h in ASM, fixed and stained with H&E, which colors nuclei dark blue and other structures (cytoplasm, collagen, etc.) pink.
(A and B) Mock-infected control; (C and D) infected with WT P. aeruginosa; (E and F) infected with the lasR::Gm mutant. Panels A, C, and E show tissue at
magnification	100 with a 100Mscale bar; panels B, D, and F show tissue at magnification	400 with a 50Mscale bar. In panel A, note two bronchioles (Br)
with diagnostic folded epithelium of brush border, example of a blood vessel (V), and lace-like pattern of alveoli defined by thin epithelium (example outlined;
A). Small patches of cellular debris are visible in the alveoli (three examples are circled). In panel B, occasional cells with horseshoe-shaped nuclei (circled) are
visible, whichmay represent neutrophils, alongwith enucleate red blood cells (two examples are boxed).Note in panels C andD the loss of clear epithelium, lower
number of nuclei, and a decreased volume of airspace. In panels E and F, this change is less extreme, with thickened outlines of epithelium still discernible.
P. aeruginosa Infection of Ex Vivo Pig Lung
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operon by reporter bacteria, aliquots of nonfiltered, undiluted homoge-
nate were assayed for luminescence. Spectrophotometric assays were
carried out using either a Tecan Infinite F200 Pro instrument (3-oxo-C12-
HSL biosensor, protease, luminescence) or a Molecular Devices Spectra-
MaxM2 instrument (pyoverdine, pyochelin, and pyocycanin). Finally, to
assess tissue damage and bacterial growth, cubes were fixed in formalin,
sectioned, and stained with hematoxylin and eosin (H&E) and Gram’s
stain and inspected under a light microscope (Nikon Eclipse 50i with
Digital Sight DS-U3 camera).
Statistical analysis. Analysis of variance (ANOVA) with type II sums
of squares (car package [66] in R 2.14.0 [67]) was used to test for main
effects of lung and inoculum (sterile ASM and/or the different bacterial
strains) and for differential effect of inoculum in different lungs (lung-inoc-
ulum interaction when the sterile ASM control was included in the analysis,
lung-strain interaction when the sterile ASM control was excluded) on de-
pendent variables. Data on total number of CFU, relative fitness of the las-
R::Gm mutant, 3-oxo-C12-HSL concentration, protease concentration, and
phenazine reporter expressionwere transformed using the natural logarithm
whentheywereusedasdependentvariables, inorder tomeet theassumptions
of ANOVA. All P values are given for two-tailed tests.
RESULTS
P. aeruginosa causes visible tissue damage. As shown in Figure
S1 in the supplemental material, fresh uninfected lung cubes ap-
peared healthy, with open alveoli surrounded by thin, well-de-
fined epithelium. To explore the effects of lasR-mediated QS on
growth and virulence, cubes were inoculated with ca. 104 washed
overnight-culture cells of WT PAO1, two independent lasR mu-
tants (the insertional mutant PAO1 lasR::Gm and the clean
knockout PAO1 lasR), a mix of PAO1 and PAO1 lasR::Gm, or a
phenazine bioreporter strain constructed in a WT or lasR back-
ground. As a mock infection control, cubes were inoculated with
50 l sterile artificial sputum medium (ASM). A visual overview
of the final dissection and infection protocol is given in Fig. 1, and
a schematic of the experimental design is given in Fig. S2.
Mock-infected cubes retained their gross structural integrity
over 24 h at 37°C, while infected cubes lost their shape and became
soft, with visible green P. aeruginosa growth (see Fig. S3 in the
supplemental material). Microscopy of fixed and stained tissue
sections showed that mock-infected lungs showedminimal histo-
pathological changes compared with lung tissue that was fixed
and sectioned prior to infection, with only small amounts of
apoptotic/necrotic debris in the alveoli (Fig. 2A and B); in most
cases, Gram staining did not show the presence of resident bacte-
ria. Some sections of mock-infected tissue exhibited areas of
reduced alveolar volume reminiscent of areas of inflammation
in living tissue, and the least histologically normal sample also
contained large numbers of Gram-negative rods; it is highly
unlikely that these were P. aeruginosa, since we never recovered
P. aeruginosa when we plated out mock-infected lung homoge-
nate. As exemplified in Fig. 2C and D, sections of tissue infected
with PAO1WThad no remaining alveolar structure, and far fewer
cell nuclei were visible than in mock-infected tissue. Tissue pres-
ervation appeared slightly better in lung tissues infected with the
lasR::Gmmutant; as exemplified in Fig. 2E and F, these weremore
reminiscent of highly inflamed tissue. In infected tissues, Gram
staining revealed large numbers of Gram-negative rods, which we
presume to be P. aeruginosa (see Fig. S4 in the supplemental ma-
terial).
lasR mutants do not show a growth disadvantage in EVPL.
We compared the fitness of WT and lasR mutant genotypes in
single and mixed infections of EVPL. P. aeruginosa grew in the
lungs (Fig. 3), reaching final densities of 6	 105 to 4	 109 CFU
per cube (5 	 103 to 3 	 107 CFU per mm3 of tissue). The final
density differed between strains (F3,36  4.48; P  0.009) and
between lungs (F2,36  19.2; P  0.001); crucially, the different
strains showed consistent differences in growth across the differ-
ent lungs (interaction F6,36  0.830; P  0.555). Post hoc Tukey
honestly significant difference (HSD) comparisons showed that
QS mutants grew as well (for the lasR mutant, P  0.297) or
better (for the lasR::Gmmutant, P 0.049) than theWT in single
infections. The mixed infections were initiated with a mixture
comprising ca. 60% WT/40% lasR::Gm mutant, and these fre-
quencies did not change over the incubation period: the relative
fitness of the mutant did not vary between lungs (ANOVA for
effect of lung; F2,7  0.04; P  0.97) and was not significantly
different from 1 (post hoc t test, t 0.62; P 0.56).
To determine whether the relative fitness of the lasR mutant
was due to growth in lung tissue and not simply to growth inASM,
we performed a control experiment in which the cube of EVPL
was replaced with a corresponding volume of ASM. Pure cultures
of the lasR::Gm andlasRmutants grew to approximately half the
density of the WT (P  0.001 and P  0.013, respectively); the
final density of the mixed WT plus lasR::Gm population did not
differ significantly from that of theWT (P 0.060). These results
are shown in Figure S5 in the supplemental material; P values are
from post hoc tests after a fully factorial ANOVA testing for the
effects of strain and experimental replicate (strain F3,47  7.69;
P 0.001). The lasR::Gm mutant was not able to take advantage
of the WT in mixed culture; its relative fitness did not differ in
pure and mixed culture (fully factorial ANOVA including exper-
imental replicate: strain F1,23 3.40; P 0.078) and was signifi-
cantly1 in both cases (post hoc t test, t 2.25; P 0.034). This
FIG 3 Number of CFU of P. aeruginosa recovered from ex vivo pig lung cubes
after 24 h of incubation in artificial sputum medium. Different symbols show
cubes from independent lungs, and bars denote overallmeans.Where pairwise
differences between strains were found to be significant (P  0.05) using
Tukey HSD tests, this is indicated with an asterisk.
Harrison et al.
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appeared to be due to the WT growing better in the absence of
EVPL than in its presence, but further work is needed to explore
this.
P. aeruginosa virulence factor expression in EVPL is QS de-
pendent. We used an E. coli bioreporter (63) to measure 3-oxo-
C12-HSL in cell-free homogenates of mock-infected and infected
lung. As shown in Fig. 4, the amount of signal produced differed
between inocula (F2,36 28.6; P 0.001) but not between lungs
(main effect, F3, 36 0.50;P 0.611; interaction, F6,36 1.39;P
0.24). This was due to the WT infection producing more signal
than the control or lasRmutant infections (Tukey HSD tests, P
0.001; mutant infections did not differ from the control [P 
0.7]). The WT produced, on average, 16 nM 3-oxo-C12 HSL
(range, 6 to 47 nM). We reran these analyses excluding the mock-
infected control and included total CFU in the cube as a covariate
to eliminate the possibility that any differences between strains
were due to variability in population density; the results were un-
changed.Many secretedmolecules that have been linked with vir-
ulence in acute infection models or with acute exacerbations or
more rapid decline of lung function in CF are under QS control.
These include tissue-degrading proteases (55) and redox-active
phenazine compounds (55–57). We then sought to determine
whether mutations in lasR and concomitant loss of 3-oxo-C12-
HSL led to decreased production of protease, phenazines, and
siderophores in EVPL.
Consistent with lower levels of tissue damage (Fig. 2), the lasR
mutants produced less protease per capita than the WT (strain,
F3,36 8.77; P 0.001; lung, F2,36 12.5; P 0.001; interaction,
F6,36 1.28; P 0.29), and this translated into much lower total
protease in lung cubes (Fig. 5). Analysis including mock-infected
cubes: inoculum, F4,45  148; P  0.001; lung, F2,45  14.0; P 
0.001; interaction, F8,45  7.4; P  0.001). On average, the total
protease activities in cubes infectedwith thelasRmutant and the
lasR::Gm mutant were 16% and 12%, respectively, of that mea-
sured in WT-infected cubes. Mock-infected cubes contained no
measurable protease (t 0.581; P 0.56), underlining the loss of
immune activity in this model. We reran the per capita and total
protease analyses excluding the mock-infected control and in-
cluded total CFU in the cube as a covariate to eliminate the possi-
bility that our results were due to variability in population density;
the results for the main effects of lung and strain were unchanged,
but the lung-strain interaction became nonsignificant in both
cases (P 0.1).
Similar results were obtained for the phenazine compound
pyocyanin (Fig. 6. Analysis including mock-infected cubes: inoc-
ulum, F4,45  12.7; P  0.001; lung, F2,45  2.47; P  0.096;
interaction, F8,36  2.18; P  0.047; dropping two outliers from
the control group did not affect these results). Visual inspection of
cubes infected with a luminescent reporter for the phenazine bio-
synthetic operon phzA1 using a photon-counting camera con-
firmed that this operon was expressed in infected cubes (Fig. 7A),
and plating confirmed that phenazine reporter constructs grew to
similar densities regardless of whether they were in aWT orlasR
genetic background. A quantitative assay showed that per-CFU
expression of luminescence by the phzA1 reporter construct was
lower in the lasR background than in the WT (Fig. 7B, F1,12 
37.9; P 0.001); on average, expression in the lasR background
was 45% of that in theWT background, but the magnitude of this
difference differed between lungs (main effect, F2,12  1.22; P 
0.33; interaction, F2,12 16.9; P 0.001). Again, including total
CFU in the cubes as a covariate did not affect the results for pyo-
FIG 4 3-oxo-C12-HSL signal in mock-inoculated and P. aeruginosa-infected
lung cubes after 24 h incubation. Different symbols show cubes from indepen-
dent lungs, and bars denote overall means. The amount of signal in the WT-
infected cubes was significantly greater than that in cubes infected with the
other three strains (Tukey HSD tests, P 0.001).
FIG 5 Total protease in mock-inoculated and P. aeruginosa-infected lung
cubes after 24 h of incubation. Different symbols show cubes from indepen-
dent lungs, and bars denote overall means. Where pairwise differences be-
tween strains were found to be significant (P 0.005) using Tukey HSD tests,
this is indicated with an asterisk.
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cyanin and phzA1 reporter expression. We could not detect the
primary and secondary siderophores pyoverdine and pyochelin in
lung homogenates using excitation/emission assays, which have
been shown to be sensitive to 10 M pyoverdine (F. Harrison,
unpublished data) and2 M pyochelin (65).
DISCUSSION
Tractability andpotential of EVPLas an infectionmodel.Ex vivo
sections of pig lung are a tractable model for studying P. aerugi-
nosa growth and virulence. Mock-infected tissue was relatively
histologically normal after 24 h of incubation in ASM at 37°C, and
preliminary observations suggest that little further histological
change occurs in mock-infected tissue after a further 6 days of
incubation. P. aeruginosa cells could be visualized in EVPL using a
light microscope and readily recovered from tissue. Cell-free sus-
pensions of homogenized tissue could be assayed for a range of
bacterial virulence factors. The relative growth of WT and lasR
mutant bacteria in EVPL contrasted with the situation in ASM
alone: in this setting, the WT outgrew the mutants by a factor of
approximately 2:1, whereas in EVPL themutants grew aswell as or
slightly better than the WT.
A key advantage of EVPL is the chance to study bacterial viru-
lence factor production, growth, and cell-cell interactions in a
spatially structured environment. A diverse literature has ex-
plored the potential effects on bacterial gene expression, growth,
and virulence of interactions between cells of the same or different
species (4, 16, 27, 68–73) and how population structure can affect
these interactions (22, 23, 35, 74). However, while it is clear that
the CF infection community is spatially structured on a gross
anatomical level (15, 75, 76), we do not know whether this com-
munity is spatially ordered at a scale relevant to bacterial cell-cell
interactions. This means that it is hard to assess the likely efficacy
of proposed clinical interventions that rely on disrupting cell-cell
interactions, such as QS inhibitors (54). Further, spatial structur-
ing of bacterial populations will affect other processes relevant to
the development of chronic infection, such as the dynamics of
bacteriocin-producing and -sensitive strains (77), plasmid trans-
fer (78), and the evolution of antibiotic resistance (79, 80). The
potential to manipulate the infection community inoculated into
EVPL, to study its evolution using conventional and confocal mi-
croscopy of sections taken at various times postinoculation, and to
correlate aspects of community diversity and structure with his-
topathology and levels of virulence factors represents a significant
opportunity to study the extent and consequences of cell-cell in-
teractions in lung tissue.
Clearly, EVPL also has limitations, and future workmust iden-
tify these, circumvent them where possible, and clarify the extent
to which EVPL represents a chronically infected human lung.
First, we must acknowledge the high variance in the data pre-
sented in this article. Since we had no a priori expectations of the
likely level of variability or ease of replication, this should be
viewed mainly as a proof-of-principle study which can be built
upon by ourselves and others. As a result of this work, we now
know that we can readily access and process lungs in batches and
easily cut several dozen regular cubes of tissue from each lung.
This knowledge, along with the ability to use the data presented
here in power calculations, will allow researchers to design larger-
scale experiments which provide more reliable estimates of be-
tween-strain or between-genotype differences. Second, if we are to
determine how well this model recapitulates chronic infection in
humans, a detailed exploration of the chemical environment in
EVPL and how this coevolves with infecting microbes over time
(days to weeks) is required. For instance, we do not yet know
whether the reported chemical similarities between human and
pig lung aremaintained in this ex vivo system or whether the ASM
FIG 6 Pyocyanin (A695) in mock-inoculated and P. aeruginosa-infected lung
cubes after 24 h of incubation. Different symbols show cubes from indepen-
dent lungs, and bars denote overall means. Where pairwise differences be-
tween strains were found to be significant (P 0.006) using Tukey HSD tests,
this is indicated with an asterisk.
FIG 7 (A) Photon-counting image of cubes taken from one lung after 24 h of
incubation. Mock-inoculated cubes and cubes infected with unlabeled
NPAO1 show no luminescence, and cubes infected with phzA1-luxCDABE
reporters show luminescence. (B) Per-CFU expression of phzA1 by P. aerugi-
nosa in lung cubes (arbitrary luminescence units divided by CFU and blanked
on samples from cubes infected with the unlabeled NPAO1). Different sym-
bols show cubes from independent lungs, and bars denote overall means. The
asterisk denotes a significant difference between strains in ANOVA (P 
0.001).
Harrison et al.
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needs to be modified when it is used in conjunction with tissue
(for example, ASM contains iron, but if this is also supplied in
abundance by the lung tissue, then overall levels of bioavailable
iron may be unrealistically high, and this could explain why sid-
erophore gene expression appeared to be switched off in our ex-
periment). Further, the oxygen regime in infected lungs is likely to
be an important factor, and infection focimay become less aerobic
over the course of infection (81, 82). Future work could address
how and when oxygen levels change inside sections of EVPL and
how this affects the growth and virulence of P. aeruginosa. Finally,
a careful comparison of results obtained in EVPL with those ob-
tained from live animal models, with clinical data from CF pa-
tients where applicable, will help us to determine whether the
differences we observe between genotypes in this model are likely
to be meaningful in vivo.
Role of QS and fitness consequences of lasR mutation in
EVPL. 3-Oxo-C12-HSL accumulated to nanomolar levels after 24
h of infection with WT PAO1. It is hard to know how this corre-
sponds to the level of expression in CF lungs, since studies using
various assay methods report concentrations ranging from fem-
tomolar to micromolar in CF secretions and tissues (83–88). We
detected significant differences between WT PAO1 and lasR mu-
tants, which do not respond to 3-oxo-C12-HSL. lasRmutants pro-
ducednodetectable 3-oxo-C12-HSL and significantly less protease
and pyocyanin than the WT; further, expression of one of the
phenazine biosynthetic operons, phzA1, was significantly re-
duced. Consistent with these results, lasR mutant-infected tissue
exhibited qualitatively less tissue damage. We therefore conclude
that P. aeruginosa “senses a quorum” in EVPL. Moreover, our
results are consistent with reports that P. aeruginosa isolates from
CF patients undergoing periods of acute exacerbation overpro-
duce various QS-dependent exoproducts (8, 55, 89) and that in P.
aeruginosa mouse infection models, areas of tissue with higher
N-acylhomoserine lactone (AHL) concentrations exhibit more
severe pathological changes (86), and lasR mutants cause less tis-
sue damage than the WT (36). That our lasR mutants showed
reduced pyocyanin production is interesting, because in stan-
dard laboratory medium in vitro, lasR mutants have been re-
ported to produce significantly more pyocyanin than the WT
(90, 91). In contrast, other studies have shown that among P.
aeruginosa clones isolated fromCFpatients, lasRmutation is often
associatedwith a loss of pyocyanin production in vitro (55; see also
reference 92).
A key finding from our study is that lasRmutants grew as well
as or better than the WT in EVPL. This is noteworthy because
there has been considerable debate about the evolutionary dy-
namics of lasR mutants in chronic infection. There are at least
three possible explanations for the presence of lasRQS-blind mu-
tants in chronic P. aeruginosa infections. First, loss of QS response
could be adaptive, conferring a growth or persistence advantage in
the context of an established infection. Second, lasRmutants may
act as social “cheats” and persist because they take advantage of
coinfecting QS-proficient genotypes, whose QS-dependent exo-
products may benefit any cell in the vicinity, regardless of its own
level of production (22, 93–96). Third, QS-blind mutants may be
maladaptive but arise due to recurrentmutation and persist at low
frequencies due to stochastic evolutionary drift. It is difficult to
choose which of these alternatives (if any) is correct, because there
is very little quantitative data on the frequency of QS-blind mu-
tants within chronically infected hosts and how this changes (or
not) over time.
Generally, the first hypothesis, that QS-blind mutants have a
fitness advantage, has had little support, because loss of lasR func-
tion reduces the ability of P. aeruginosa to establish acute infec-
tions (31–36). We also found that in ASM in the absence of pig
lung, lasRmutants were less fit than the WT. These observations,
combined with demonstrations that lasRmutants can act as WT-
exploiting cheats in some situations in vitro (22, 26, 97, 98) and in
acute burn wound infections (32, 35), have led some researchers
to give the second hypothesis serious consideration. This has led
to the idea of deliberately introducing cheating mutants to trigger
population collapse or to act as “Trojan horses” for carrying useful
alleles (e.g., antibiotic susceptibility) into infectious populations
(e.g. see reference 99).
Our result is not consistent with the “social cheat” hypothesis.
Rather, it adds weight to the first hypothesis: that loss of LasR
function enhances growth in chronic infection. The chemical en-
vironment in chronically infected, damaged tissues may confer a
growth advantage on lasR-null mutants; D’Argenio et al. (100)
report that the relative growth ofWT and lasR-null monocultures
in vitro is dependent on medium composition and that in some
media, lasR-null mutants outgrow theWT. In addition, Duan and
Surette (101) show that changes to medium composition can
change theway that theQS system reacts to cell density.Moreover,
in one of the few studies to track the frequency of lasR-null P.
aeruginosa in human patients over the course of infection, Köhler
et al. (50) interpret their data as showing that lasR mutants are
cheats, but they report that patients colonized only by lasR mu-
tants had bacterial loads similar to those of patients colonized only
by the WT, and this strongly suggests that these mutants are not
impaired in chronic persistence. For a detailed discussion of the
evidence for adaptive loss of LasR, we refer the reader to the review
by Heurlier et al. (102), and for a detailed discussion of social
cheating, see Ghoul et al. (51).
We could not detect production of the siderophores pyover-
dine and pyochelin in EVPL.While siderophores are necessary for
acute infections of mice (58) and waxmoth larvae (27), their role
in chronic CF lung infection is unclear because tissue damage and
low oxygen levels may render iron more accessible (103–106).
Studies of CF sputum samples have shown that siderophores are
sometimes, but not always, present at detectable levels (61, 62).
Future directions. Further optimization of EVPL could render
it a realistic, ethical, and high-throughput model for studying the
evolutionary ecology and pathology of chronic lung infection. As
discussed above, several questions regarding the biological realism
of themodel remain to be answered, but themethodologywe have
developed for processing and handling lung tissue will allow us
and others to address these in detail. The model as presented here
produced more extensive and less localized tissue damage than
seen in postmortem CF lungs, but since we inoculated with a high
dose of bacteria and used aerobic culture conditions, this is not
surprising.Now thatwe have demonstrated the potential of EVPL,
the next steps in developing the model will be to find conditions
that produce stable and long-lived infections (e.g., by titrating the
number of cells inoculated, culturing under microaerobic or an-
aerobic conditions, and simulating key aspects of the host im-
mune response). In this study, we used alveolar tissue tominimize
between-cube variation in structure, but future work could focus
on dissecting regular sections of bronchiole, since these are the
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foci of infection in human CF lungs (107). A comparison between
lung cubes obtained from healthy pigs and lung cubes taken from
pigs genetically engineered to express human CFmutations (114)
may also help to validate the system. In the future, EVPL could
especially enhance research into interactions betweenmicrobes in
multispecies infections, which are the norm in CF (13, 15, 108–
110) and are increasingly recognized as important in other respi-
ratory diseases, such as chronic obstructive pulmonary disease
(COPD) and asthma (111–113).
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